COLOPLAST A/S/ADR (OTCMKTS:CLPBY) hit a new 52-week high on Thursday . The company traded as high as $12.57 and last traded at $12.28, with a volume of 355 shares trading hands. The stock had previously closed at $12.53.
A number of brokerages recently weighed in on CLPBY. Barclays cut shares of COLOPLAST A/S/ADR from an “overweight” rating to an “equal weight” rating in a research note on Friday, July 19th. ValuEngine cut shares of COLOPLAST A/S/ADR from a “buy” rating to a “hold” rating in a research note on Thursday, August 1st.
The business’s 50 day moving average is $11.96 and its two-hundred day moving average is $10.90. The company has a quick ratio of 0.78, a current ratio of 1.12 and a debt-to-equity ratio of 0.01. The firm has a market capitalization of $26.52 billion, a P/E ratio of 42.34 and a beta of 0.50.
Coloplast A/S develops and markets intimate healthcare products and services worldwide. The company operates through three segments: Chronic Care, Interventional Urology, and Wound & Skin Care. It provides ostomy care products, including SenSura Mio, which provides fit to individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand.
See Also: Different Options Trading Strategies
Receive News & Ratings for COLOPLAST A/S/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for COLOPLAST A/S/ADR and related companies with MarketBeat.com's FREE daily email newsletter.